Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000486

Drug Information
NameNicardipine    
SynonymsIDI1_033859; L000715; AC1L1I8Y; methyl 2-[methyl(phenylmethyl)amino]ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; NCGC00015747-06; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-(benzylmethylamino)ethyl methyl ester; DB00622; NCGC00162262-04; Ambap55985-32-5; 5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; BRN 0504321; NCGC00162262-02; EINECS 259-932-3; C07264; HMS1989F11; Nicardipinum [INN-Latin]; Bio2_000589; Y-93; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester; HMS2089C09; KBioSS_000109; KBioSS_001852; Spectrum_001372; MolPort-002-484-049; LS-131263; Bio2_000109; KBioGR_000744; Spectrum5_001320; CHEMBL1484; Bio1_000088; KBio2_006988; HMS1791F11; Prestwick2_000383; Spectrum4_000422; BSPBio_001389; Lopac0_000809; BSPBio_000565; KBio2_004420; DivK1c_000540; Prestwick1_000383; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]ethyl ester; CID4474; BIDD:GT0621; BRD-A26711594-001-02-7; Oprea1_436998; Nicardipine (INN); SPBio_002486; Spectrum2_001415; KBio2_000109; KBio2_001852; BSPBio_002943; IDI1_000540; Nicardipino; Nicardipine LA; CBiol_001802; Bio1_000577; Nicardipine [INN:BAN]; nicardipine; NCGC00162262-03; NCGC00162262-01; KBio1_000540; C26H29N3O6; 55985-32-5; BPBio1_000623; Bio1_001066; NINDS_000540; KBioGR_000109; KBio2_005245; Prestwick0_000383; KBio3_002443; D08270; Prestwick3_000383; 2-(Benzylmethylamino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate; CHEBI:507549; KBio3_000218; AB00514658; KBio3_000217; KBio2_002677; Cardene IV; AC-19947; Nicardipinum; Cardene (TN); BRD-A26711594-003-05-6; Spectrum3_001452; AKOS001637090; Nicardipino [INN-Spanish]; SPBio_001490; UNII-CZ5312222S    
Trade NameCardene    
IndicationHigh blood pressure and anginaApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntihypertensive Agents    
CAS NumberCAS 55985-32-5
FormularC26H29N3O6    
PubChem Compound IDCID 4474.    
PubChem Substance IDSID 9473.    
SuperDrug ATC IDC08CA04;    
SuperDrug CAS ID055985325;    
TargetCalcium channelBlocker[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 022276 To Reference
Ref 2Effect of intracoronary nicardipine on cardiac enzymes after elective percutaneous coronary intervention. Clin Cardiol. 2009 Jun;32(6):315-20. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543